Ceribell (CBLL) Cash from Operations (2023 - 2026)
Ceribell (CBLL) posted Cash from Operations of 19297000.0 for Q1 2026, down 79.11% on a QoQ basis from 10774000.0 in Q4 2025, and down 69.23% year-over-year from 62708375.89 in Q1 2025.
Ceribell (CBLL) Cash from Operations (2023 - 2026) Analysis & Trends
Ceribell's Cash from Operations history runs 4 years deep, the most recent figure standing at 19297000.0 for Q1 2026.
- Quarterly Cash from Operations fell 69.23% year-over-year to 19297000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 48702000.0 (down 32.0% YoY) and the FY2025 annual result came in at 40808000.0, down 16.45% from the prior year.
- Cash from Operations was 19297000.0 for Q1 2026 at Ceribell, down from 10774000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 6675000.0 in Q4 2023 and bottomed at 19297000.0 in Q1 2026.
- A 4-year average of 10182300.0 and a median of 9762500.0 in 2024 frame the typical range for Cash from Operations.
- Annual changes were most pronounced in 2025 — Cash from Operations declined 7.98% — and 2026, when it plunged 69.23%.
- Ceribell's Cash from Operations stood at 6675000.0 in 2023, then tumbled by 49.44% to 9975000.0 in 2024, then dropped by 8.01% to 10774000.0 in 2025, then tumbled by 79.11% to 19297000.0 in 2026.
- Business Quant data shows CBLL's Cash from Operations at 19297000.0 in Q1 2026, 10774000.0 in Q4 2025, and 11098000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Ceribell | 613.16 Mn | 471.97 Mn | 23.12 Mn | -19.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.30 Mn |
| Mar 31, 2026 | -19.30 Mn |
| Dec 31, 2025 | -10.77 Mn |
| Dec 31, 2025 | -10.77 Mn |
| Sep 30, 2025 | -11.10 Mn |
| Sep 30, 2025 | -11.10 Mn |
| Jun 30, 2025 | -7.53 Mn |
| Jun 30, 2025 | -7.53 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Mar 31, 2025 | -11.40 Mn |
| Dec 31, 2024 | -9.98 Mn |
| Dec 31, 2024 | -9.98 Mn |
| Sep 30, 2024 | -8.54 Mn |
| Sep 30, 2024 | -8.54 Mn |
| Jun 30, 2024 | -6.98 Mn |
| Jun 30, 2024 | -6.98 Mn |
| Mar 31, 2024 | -9.55 Mn |
| Mar 31, 2024 | -9.55 Mn |
| Dec 31, 2023 | -6.68 Mn |
| Dec 31, 2023 | -6.68 Mn |